SAN FRANCISCO, CA & PHILADELPHIA, PA — Vivodyne has raised $40 million in Series A funding to expand its cutting-edge robotics and AI platform, which uses lab-grown human tissues to … ...

Expansion of Predictive's AI-driven drug discovery platform to include biomarker discovery and drug repurposing, positioning the company to capitalize on a rapidly growing market projected at $14. ...

Nvidia (NASDAQ:NVDA) announced a collaboration with Novo Nordisk (NVO) (OTCPK:NONOF) on Wednesday to speed up the Danish pharma giant's efforts in drug discovery using artificial intelligence. Its ...

Nvidia-backed AI firm Iambic unveils drug discovery ‘breakthrough’ By Martin Coulter October 29, 20244:08 AM PDTUpdated October 29, 2024 ...

Significant capital is being invested in artificial intelligence for drug discovery, yet traditional drug development is notoriously slow, inefficient and risky. Enter BioPhy. The Philly-based startup ...

For him, the real promise of A.I. is in refining the entire drug discovery pipeline, including clinical trial optimization. Mergers and acquisitions also present a tantalizing opportunity.

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...